Meeting
2014 Gastrointestinal Cancers Symposium
Prospective observational study on chemotherapy-induced nausea and vomiting (CINV) for hepatobiliary and pancreatic cancer patients who were to receive chemotherapy including cisplatin by the CINV study group of Japan.
Authors
Junji Furuse
Department of Internal Medicine, Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan
Junji Furuse , Hideo Baba , Shinichi Ohkawa , Kazuya Sugimori , Kazuhide Yamamoto , Hironobu Minami , Yuko Kitagawa , Hidekazu Kuramochi , A-Hon Kwon , Michiaki Unno , Go Wakabayashi , Keisuke Aiba , Kazuo Tamura
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 341)
DOI
10.1200/jco.2014.32.3_suppl.341
Abstract #
341
Poster Bd #
C56
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
A prospective observational study on chemotherapy-induced nausea and vomiting for esophageal cancer patients in Japan.
First Author: Sachiko Yamamoto
Poster
2020 ASCO Virtual Scientific Program
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting (CINV): Results of the Nausea/Emesis Registry in Oncology (NERO).
First Author: Matti S. Aapro
Poster
2020 ASCO Virtual Scientific Program
Antiemetic prophylaxis with NEPA: Final results of the German AKYPRO study.
First Author: Joerg Peter Schilling
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Rolapitant for the prevention of nausea in patients receiving moderately or highly emetogenic chemotherapy.
First Author: Rudolph M. Navari